Reduction in Urinary CD163 Is Associated with Treatment Response in the Belimumab Lupus Nephritis Trial

被引：0
|
作者：
Weeding, Emma [1 ]
Fava, Andrea [1 ]
Mohan, Chandra [2 ]
Goldman, Daniel
Petri, Michelle [3 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD USA
[2] Univ Houston, Houston, TX USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1737
引用
收藏
页码：3619 / 3621
页数：3
相关论文
共 50 条
  • [21] Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of 'soluble CD163' in plasma
    Etzerodt, Anders
    Berg, Ronan M. G.
    Plovsing, Ronni R.
    Andersen, Morten N.
    Bebien, Magali
    Habbeddine, Mohamed
    Lawrence, Toby
    Moller, Holger J.
    Moestrup, Soren K.
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Belimumab for the treatment of pediatric patients with lupus nephritis
    Stohl, William
    Kwok, Alyssa
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (03) : 243 - 251
  • [23] ASSOCIATION OF GLOMERULAR MACROPHAGE PHENOTYPES AND URINE SOLUBLE CD163 WITH DISEASE ACTIVITY IN HUMAN LUPUS NEPHRITIS
    Nobuhide, Endo
    Naotake, Tsuboi
    Kazuhiro, Furuhashi
    Seiichi, Matsuo
    Shoichi, Maruyama
    NEPHROLOGY, 2014, 19 : 148 - 148
  • [24] ASSOCIATION OF GLOMERULAR MACROPHAGE PHENOTYPES AND URINE SOLUBLE CD163 WITH DISEASE ACTIVITY IN HUMAN LUPUS NEPHRITIS
    Endo, Nobuhide
    Tsuboi, Naotake
    Furuhashi, Kazuhiro
    Matsuo, Seiichi
    Maruyama, Shoichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 435 - 436
  • [25] Urinary soluble CD163 is useful as "liquid biopsy" marker in lupus nephritis at both diagnosis and follow-up to predict impending flares
    Renaudineau, Yves
    Chauveau, Dominique
    Faguer, Stanislas
    Huart, Antoine
    Ribes, David
    Pugnet, Gregory
    Sailler, Laurent
    Jamme, Thibaut
    Treiner, Emmanuel
    Fortenfant, Francoise
    Bost, Chloe
    Carle, Caroline
    Belliere, Julie
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2024, 9
  • [26] Urinary Soluble CD163 in Active Renal Vasculitis
    O'Reilly, Vincent P.
    Wong, Limy
    Kennedy, Claire
    Elliott, Louise A.
    O'Meachair, Shane
    Coughlan, Alice Marie
    O'Brien, Eoin C.
    Ryan, Michelle M.
    Sandoval, Diego
    Connolly, Emma
    Dekkema, Gerjan J.
    Lau, Jiaying
    Abdulahad, Wayel H.
    Sanders, Jan-Stephan F.
    Heeringa, Peter
    Buckley, Colm
    O'Brien, Cathal
    Finn, Stephen
    Cohen, Clemens D.
    Lindemeyer, Maja T.
    Hickey, Fionnuala B.
    O'Hara, Paul V.
    Feighery, Conleth
    Moran, Sarah M.
    Mellotte, George
    Clarkson, Michael R.
    Dorman, Anthony J.
    Murray, Patrick T.
    Little, Mark A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (09): : 2906 - 2916
  • [27] Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China
    Yang, Guangxia
    Guo, Naifeng
    Yin, Jun
    Wu, Jianhua
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (11)
  • [28] De novo lupus nephritis during treatment with belimumab
    Parodis, Ioannis
    Vital, Edward M.
    Hassan, Sabih-Ul
    Jonsen, Andreas
    Bengtsson, Anders A.
    Eriksson, Per
    Leonard, Dag
    Gunnarsson, Iva
    Ronnblom, Lars
    Sjowall, Christopher
    RHEUMATOLOGY, 2021, 60 (09) : 4348 - 4354
  • [29] Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis (vol 13, 935700, 2022)
    Huang, Yun-Ju
    Lin, Chiung-Hung
    Yang, Huang-Yu
    Luo, Shue-Fen
    Kuo, Chang-Fu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Association of Glomerular Macrophage Phenotypes and Urine Soluble CD163 with Disease Activity in Human Lupus Nephritis.
    Tsuboi, Naotake
    Endo, Nobuhide
    Matsuo, Seiichi
    Maruyama, Shoichi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S727 - S727
12345